News & Eventsnews update

Bulletin Board

bravoItems are posted on the Bulletin Board
for two months then moved
to Archived News.



Control of Glioblastoma Tumorigenesis

bravo

Congratulations to Dr. Arezu Jahani-Asl whose recent publication in Nature Neuroscience, Control of Glioblastoma Tumorigenesis by Feed Forward Cytokine Signaling, has been getting a lot of media coverage. It has been featured in articles in a number of newspapers including the UK’s Mirror as well as Medical Press.

2016-04-28

Partnership for Personalized Medicine

bravo

Exactis Innovation, co-founded by Dr. Gerald Batist who is its Scientific Director, received $4 million in partnership funding ($2 million from Merck, $1 million from the Cancer Research Society and $1 million from the New Brunswick Health Research Foundation) for its "Personalize My Treatment" initiative. Read more in the article in Med e-News.

2016-04-28
Rossy Cancer Network

bravo

Congratulations to Lawrence (Larry) G. Rossy, C.M., O.Q. on receiving an Honorary Doctor of Laws degree from McGill University.  A generous gift from the Rossy Family Foundation in 2013 paved the way for the launch of the Rossy Cancer Network initiative.

2016-04-28

Kudos

kudosCongratulations to Dr. Serge Carrier who, on April 28, 2016, will be awarded the 2016 Outstanding Contribution Award from the Prostate Cancer Canada Network - Montreal West Island support group.

2016-04-18

Better way to screen for cervical cancer

bravo

 Published on April 13, 2016 as an Opinion in Healthy Debate, Dr. Eduardo Franco makes the case for using the innovative HPV test as a better way to screen for cervical cancer.

2016-04-18

Kudos to Laurent Azoulay

bravoCongratulations to Dr. Laurent Azoulay whose research on diabetes drugs has been published recently in The New England Journal of Medicine and BMJ. The New England Journal of Medicine paper reports on a study looking at incretin-based drugs and heart failure while one study published in BMJ looks at incretin-based drugs and pancreatic cancer. A second paper in BMJ reports on a study looking at pioglitazone and bladder cancer risk (see press release issued by BMJ).

Kristian B. Filion, Laurent Azoulay, Robert W. Platt, Matthew Dahl, Colin R. Dormuth, Kristin K. Clemens, Nianping Hu, J. Michael Paterson, Laura Targownik, Tanvir C. Turin, Jacob A. Udell, M.D., M.P.H., and Pierre Ernst, M.D., for the CNODES Investigators* A Multicenter Observational Study of Incretin-based Drugs and Heart Failure N Engl J Med 374; 12 March 24, 2016

Laurent Azoulay, Kristian B Filion, Robert W Platt, Matthew Dahl, Colin R Dormuth, Kristin K Clemens, Madeleine Durand, David N Juurlink, Laura E Targownik, Tanvir C Turin,  J Michael Paterson, Pierre Ernst for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study. BMJ 2016;352:i581

Marco Tuccori, Kristian B Filion, Hui Yin, Oriana H Yu, Robert W Platt, Laurent Azoulay. Pioglitazone use and risk of bladder cancer: population based cohort study. BMJ 2016;352:i1541

2016-04-03

Canada Foundation for Innovation Grant

bravoCongratulations to Dr. Shirin Enger for receiving a John R. Evans Leaders Fund (JELF) grant from the Canada Foundation for Innovation. 

2016-03-18